Abstract
The new Duromedics Bileaflet Cardiac Valve prosthesis has a special moviṅg hinge mechanism for its two leaflets to wash the critical articulation area and thus reduce thrombus formation.
Between October 1983 and June 1985, we implanted 278 of these prostheses in 254 patients. We did 114 aortic valve replacements, 109 mitral valve replacements, 34 double valve replacements, and two tricuspid valve replacements. Nearly 20% of the patients had had previous cardiac procedures. The hospital mortality was 5.9%. Follow-up was started with 214 surviving Austrian patients, and up to the present time, we have a follow-up period of 1704 patient months. Five patients died late after the operation (3.5 per 100 patient years). We observed 10 valve-related complications in nine patients (7 per 100 patient years). There were three cases of prosthetic endocarditis (2.1 per 100 patient years), two paravalvular leaks, and four bleeding episodes (2.8 per 100 patient years). The mechanical hemolysis was minimal, and the postoperative hemoglobin value averaged 15 g%. The LDH increased from 230 IU to 307 in the aortic valve replacements, 406 in the mitral valve replacements, and 435 in the double valve replacements. Intraoperative pressure gradients and postoperative Doppler echocardiography showed good hemodynamic performance.
We conclude that good clinical results and a low complication rate can be achieved with the Duromedics Valve.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Björk V. O., Henze A. Ten years' experience with the Björk-Shiley tilting disc valve. J Thorac Cardiovasc Surg. 1979 Sep;78(3):331–342. [PubMed] [Google Scholar]
- Dale J., Myhre E. Intravascular hemolysis in the late course of aortic valve. Am Heart J. 1978 Jul;96(1):24–30. doi: 10.1016/0002-8703(78)90122-9. [DOI] [PubMed] [Google Scholar]
- Dumoulin M., Tirmarche M., Horellou M. H., Acar J., Samama M. Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement. Haemostasis. 1981;10(1):28–36. doi: 10.1159/000214384. [DOI] [PubMed] [Google Scholar]
- Manohitharajah S. M., Rahman A. N., Donnelly R. J., Deverall P. B., Watson D. A. Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism. Thorax. 1974 Nov;29(6):639–642. doi: 10.1136/thx.29.6.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller D. C., Oyer P. E., Mitchell R. S., Stinson E. B., Jamieson S. W., Baldwin J. C., Shumway N. E. Performance characteristics of the Starr-Edwards Model 1260 aortic valve prosthesis beyond ten years. J Thorac Cardiovasc Surg. 1984 Aug;88(2):193–207. [PubMed] [Google Scholar]
- Nicoloff D. M., Emery R. W., Arom K. V., Northrup W. F., 3rd, Jorgensen C. R., Wang Y., Lindsay W. G. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience. J Thorac Cardiovasc Surg. 1981 Nov;82(5):674–683. [PubMed] [Google Scholar]
- Pumphrey C. W., Dawes J. Platelet alpha granule depletion: findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery. Thromb Res. 1983 May 1;30(3):257–264. doi: 10.1016/0049-3848(83)90079-8. [DOI] [PubMed] [Google Scholar]
- Teply J. F., Grunkemeier G. L., Sutherland H. D., Lambert L. E., Johnson V. A., Starr A. The ultimate prognosis after valve replacement: an assessment at twenty years. Ann Thorac Surg. 1981 Aug;32(2):111–119. doi: 10.1016/s0003-4975(10)61017-x. [DOI] [PubMed] [Google Scholar]